EXFORGE HCT 10mg/160mg/25mg Tablets (28 tablets)
Active Ingredients:
Amlodipine (as besilate) 10 mg – Calcium channel blocker
Valsartan 160 mg – Angiotensin II receptor blocker (ARB)
Hydrochlorothiazide 25 mg – Thiazide diuretic
Therapeutic Class:
Antihypertensive combination therapy
EXFORGE HCT is indicated for the treatment of:
Essential hypertension in adults whose blood pressure is not adequately controlled on monotherapy or dual therapy
Patients who require combination therapy with three antihypertensive agents for optimal blood pressure control
Amlodipine relaxes vascular smooth muscle by inhibiting calcium influx, reducing blood pressure
Valsartan blocks the effects of angiotensin II, preventing vasoconstriction and aldosterone release
Hydrochlorothiazide increases sodium and water excretion, reducing blood volume and vascular resistance
One tablet daily, taken at the same time each day
May be taken with or without food
Dosage should be individualized based on patient response and previous antihypertensive treatment
Contraindicated in pregnancy, severe hepatic or renal impairment, anuria, or hypersensitivity to any component
Monitor electrolytes, renal function, and blood pressure regularly
Caution in patients with volume depletion, electrolyte imbalances, or impaired renal function
Common: dizziness, headache, fatigue, peripheral edema, increased urination
Less common but serious: hypotension, hyperkalemia, renal impairment, electrolyte disturbances
Store below 30°C. Protect from moisture and light. Keep out of reach of children.